Thyroid Cancer Bone Metastasis: Survival and Genomic Characteristics of a Large Tertiary Care Cohort.

CONCLUSION: Patients with DTC can benefit from early treatment with external beam radiation therapy, especially those who develop bone metastasis within 3 years of primary TC diagnosis. Kinase inhibitor treatment tended to prolong survival but not in a statistically significant manner. Sex, age, and TERT or BRAF genetic mutations did not significantly affect the prognosis. PMID: 31274625 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31274625?dopt=Abstract

Source: Clinical Lung Cancer - July 7, 2019 Category: Cancer & Oncology Authors: Kondraciuk JD, Rice SL, Zhou X, Gharzeddine K, Knezevic A, Spratt DE, Sabra M, Larson SM, Grewal RK, Osborne JR Tags: Clin Nucl Med Source Type: research